Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Click here to register for Newsweek's July 21 webinar , "The 'Payvider' Perspective: How Health Systems with Health Plans are Aligning Incentives to Win Patient Trust ," featuring Andrea Walsh, president and CEO of HealthPartners
These drugs' weight-loss effects make them an appealing alternative for both patients and healthcare practitioners
For instance, tirzepatide (Mounjaro) typically costs between $345 and $645 per month, while semaglutide (Ozempic) is priced at around $42 per month under the Pharmaceutical Benefits Scheme (PBS) for managing type 2 diabetes
The key difference is that Ozempic is designed for blood sugar control, not officially for weight loss, so dosing and insurance coverage may differ
Find what works for your preferences and stick with it
